# LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
> **NDA205054** · New Drug Application · Sponsor: INVAGEN PHARMS · Approved 2018-08-28
## Drug
- **FDA Application Number:** NDA205054
- **Application type:** New Drug Application
- **Brand name:** LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
- **Generic name:** LEUPROLIDE ACETATE
- **Active ingredients:** LEUPROLIDE ACETATE
- **Dosage form:** FOR SUSPENSION
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Avyxa Pharma, LLC
- **First approval:** 2018-08-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205054)
---
*AI Analytics · CC0 1.0*